1. Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma 
Fangzheng Wang, Chuner Jiang, Zhiming Ye, Quanquan Sun, Tongxin Liu, Min Xu, Peng Wu, Kaiyuan Shi, Bin Long, Zhenfu Fu, Yangming Jiang 
Translational Oncology 
Volume 11, Issue 2, Pages (April 2018)
DOI: /j.tranon
Copyright © 2018 The Authors Terms and Conditions

2. Figure 1
Kaplan-Meier estimates of the survival of elderly patients with nasopharyngeal carcinoma. (A) local recurrence-free survival; (B) regional recurrence-free survival; (C) distance metastasis-free survival; (D) progress-free survival; (E) overall survival.
Translational Oncology  , DOI: ( /j.tranon )
Copyright © 2018 The Authors Terms and Conditions

3. Figure 2
Kaplan-Meier estimates of the survival of elderly patients’ nasopharyngeal carcinoma for different variables. (A) Overall survival for T stage; (B) Overall survival for clinical stage; (C) progress-free survival for tumor response.
Translational Oncology  , DOI: ( /j.tranon )
Copyright © 2018 The Authors Terms and Conditions

4. Figure 3
Kaplan-Meier estimates of the survival of elderly patients’ nasopharyngeal carcinoma with or with chemotherapy. (A) Overall survival of patients with or without NAC; (B) Over survival of patients with or without CC.
Translational Oncology  , DOI: ( /j.tranon )
Copyright © 2018 The Authors Terms and Conditions